Skip to main navigation
  • About Us
  • Programs
  • Join Us
  • Investors
  • Contact Us
Aerovate Therapeutics

Press Releases

Investors & Media

  •   Overview
  •   Press Releases
  •   Events & Presentations
  •   Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  •   Stock Information
    • Stock Quote & Chart
    • Investment Calculator
    • Historical Price Lookup
  •   Analyst Coverage
  •   Governance
    • Documents and Committee Composition
    • Leadership
    • Board of Directors
  •   Contact & FAQs
    • FAQs
    • Contact Us
    • Email Alerts

Stockholder Tools

  •   Print Page
  •   RSS Feeds
  •   Email Alerts
  •   Contact Us
March 29, 2023
Aerovate Therapeutics Announces Full-Year 2022 Financial Results and Business Highlights
March 2, 2023
Aerovate Therapeutics to Present at Cowen 43rd Annual Health Care Conference
January 23, 2023
Aerovate Therapeutics Appoints Donald Santel To Its Board of Directors
November 17, 2022
Aerovate Therapeutics Publishes Results of Phase 1 Study Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension in ERJ Open Research
November 14, 2022
Aerovate Therapeutics Announces Third Quarter 2022 Financial Results
October 18, 2022
Aerovate Therapeutics Presents Novel Phase 2b/Phase 3 IMPAHCT Trial Design at CHEST Annual Meeting 2022
August 15, 2022
Aerovate Therapeutics Announces Second Quarter 2022 Financial Results
June 2, 2022
Aerovate Therapeutics to Present at Jefferies Global Healthcare Conference
May 16, 2022
Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
May 16, 2022
Aerovate Therapeutics Announces First Quarter 2022 Financial Results

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 21

Investors & Media

  •   Overview
  •   Press Releases
  •   Events & Presentations
  •   Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  •   Stock Information
    • Stock Quote & Chart
    • Investment Calculator
    • Historical Price Lookup
  •   Analyst Coverage
  •   Governance
    • Documents and Committee Composition
    • Leadership
    • Board of Directors
  •   Contact & FAQs
    • FAQs
    • Contact Us
    • Email Alerts

Stockholder Tools

  •   Print Page
  •   RSS Feeds
  •   Email Alerts
  •   Contact Us
Aerovate Therapeutics
  • About Us
  • Programs
  • Join Us
  • Investors
  • Contact Us

© 2023 Aerovate Therapeutics, Inc. All Rights Reserved. | Privacy Policy | Terms of Use